# Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function

> **NCT01899573** · NA · COMPLETED · sponsor: **Ancora Heart, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Functional Mitral Regurgitation

## Interventions

- **DEVICE:** AccuCinch® Ventriculoplasty System

## Key facts

- **NCT ID:** NCT01899573
- **Lead sponsor:** Ancora Heart, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01899573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01899573, "Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01899573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*